Recent Alert on 06/04/09 at 11:51am
Hemispherx (HEB) Continuing Higher as Japanese Researchers Call Ampligen(r) 'Most Promising' Candidate for Flu Vaccines Shares of the momentous Hemispherx BioPharma (AMEX: HEB) are adding another 16% onto recent gains today following news earlier that scientists at the Japanese National Institute of Infectious Diseases called the company's Ampligen(r) "the most... Read More
----------------------------------------------------------------------
Hemispherx (HEB) Continuing Higher as Japanese Researchers Call Ampligen(r) 'Most Promising' Candidate for Flu Vaccines Shares of the momentous Hemispherx BioPharma (AMEX: HEB) are adding another 16% onto recent gains today following news earlier that scientists at the Japanese National Institute of Infectious Diseases called the company's Ampligen(r) "the most... Read More
----------------------------------------------------------------------
I have enough shares, if it hits, I'll be happy.
If it's true that they have an inside track on a flu vaccine and FDA approval may happen within two weeks, it's going to go way beyond it's present price.
If it's true that they have an inside track on a flu vaccine and FDA approval may happen within two weeks, it's going to go way beyond it's present price.
the complete release
9:31AM Hemispherx Biopharma announces Japanese National Institute of Infectious Diseases scientists identify its drug technology as the "most promising mucosal adjuvant for influenza" (HEB) 2.68 +0.14 : Co announces that a new publication summarizes ongoing research in which researchers conclude that Poly I
olyC12U (Ampligen, an experimental therapeutic, is the "most promising adjuvant candidate for mucosal vaccines." Ampligen was also "extremely important" in these studies, in that it produced cross-protection against variant influenza viruses not seen with the vaccines given alone." The conclusion of the JIID researchers is that a pandemic of new influenza virus seems possible, and because it will be difficult to know when a pandemic will occur (or which strain of virus will be the cause), it is in the global community's best interest to develop broadly effective and safe vaccines against influenza virus. Hence, in the need for development of a broadly effective vaccine, induction of mucosal immunity is an inevitable requirement, as mucosal secretory IgA plays an important role in cross protection.
9:31AM Hemispherx Biopharma announces Japanese National Institute of Infectious Diseases scientists identify its drug technology as the "most promising mucosal adjuvant for influenza" (HEB) 2.68 +0.14 : Co announces that a new publication summarizes ongoing research in which researchers conclude that Poly I
olyC12U (Ampligen, an experimental therapeutic, is the "most promising adjuvant candidate for mucosal vaccines." Ampligen was also "extremely important" in these studies, in that it produced cross-protection against variant influenza viruses not seen with the vaccines given alone." The conclusion of the JIID researchers is that a pandemic of new influenza virus seems possible, and because it will be difficult to know when a pandemic will occur (or which strain of virus will be the cause), it is in the global community's best interest to develop broadly effective and safe vaccines against influenza virus. Hence, in the need for development of a broadly effective vaccine, induction of mucosal immunity is an inevitable requirement, as mucosal secretory IgA plays an important role in cross protection.
What a day!!!!
Very solid day everyone! I am so anxious!! I honestly don't think we see any news tomorrow. I think they will announce it Monday morning, but everything is just a guess anymore. One thing is for sure. .. It will be either Friday, Monday, or Monday AH. I am so excited. I am rolling half of it into CTIC after this one, and keeping the other half in long term. This thing could be a $30+ drug with all of the things it can be used for!
<input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden">
<input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden">
I think your safe tomorrow. My personal opinion is that they won't announce until after the weekend. Who knows but I don't think many approvals happen at the end of the week. Ya never know though.
<input id="gwProxy" type="hidden"><!--Session data--><input onclick="jsCall();" id="jsProxy" type="hidden">
serious trading going on
closed at 3.75
opened at 4.09
shot up to 4.54
crashed to 2.12
presently 3.35
avg volume 10,000,000
2.5 hours today 38,000,000
I agree with DEC, some people on the outside calling it a fraud hurt. I also think there as got to be some profit taking going on.
closed at 3.75
opened at 4.09
shot up to 4.54
crashed to 2.12
presently 3.35
avg volume 10,000,000
2.5 hours today 38,000,000
I agree with DEC, some people on the outside calling it a fraud hurt. I also think there as got to be some profit taking going on.
looks like the guy who wrote the piece has been bashing HEB from day 1, now he's getting defensive about being called out.
doesn't take much to derail a penny stock after a big run.
